started in 2011 online pharmacies, and now into the explosive growth phase. Recently, the China health information released data show that: in 2013, China’s online pharmacy sales of about 4 billion 200 million yuan, compared with 2012 turned over the times, and is expected in 2014, China’s pharmaceutical electricity supplier transaction size will reach $6 billion 800 million.
Guangzhou Pharmaceutical Group Chairman, party secretary Li Chuyuan believes that the pharmaceutical health industry has become the last piece of e-commerce cake". 2013, China’s pharmaceutical e-commerce scale of 4 billion 260 million yuan, accounting for only less than the entire e-commerce market, but compared with the $1 billion 660 million in 2012, in 2011 of $400 million, the average growth rate of over 200%.
2013, the scale of the pharmaceutical B2C transaction began to show explosive growth, as of the end of 2013, the food and Drug Administration registered online pharmacies to get a license to have 150, to grow to 193 in June 2014.
insiders said that with the increase in the number of pharmaceutical enterprises B2C, further promote the development of pharmaceutical retail B2C online shopping market, Tmall and Jingdong mall major electricity supplier platform to promote the interventional medicine B2C transaction size and user demand.
2013, Tmall medical library to achieve a total transaction of about 2 billion yuan, accounting for almost half of the total size of the pharmaceutical electricity supplier, while the vertical class pharmaceutical electricity supplier to do the best of less than $400 million, most of the profits or even lose money.
a number of industry insiders believe that with the growing maturity of electricity providers and online shopping, Tmall, Jingdong and other large B2C trading platform to participate in the future of online pharmacies channels will continue to grow rapidly.
however, Li Chuyuan said that China’s policy on drug online transactions more stringent regulation of the higher threshold, a certain extent to protect the pharmaceutical industry from the impact of the electricity supplier predators, but also restricts the development of pharmaceutical electricity supplier.
in May 28th this year, the State Food and Drug Administration issued a "Internet operating food and drug supervision and management measures" (Draft), the approach is the industry generally considered a precursor to open the gate of pharmaceutical business.
Li Chuyuan believes that the measures may bring three big opportunities for the development of pharmaceutical electricity supplier: prescription drugs can be sold online, this is the greatest impact on the most controversial; business or non chain pharmacies sell drugs online allows third party logistics and distribution of drugs. Driven by the policy, the rapid development of e-commerce in China’s pharmaceutical industry, pharmaceutical industry, product sales channels continue to widen, however, the traditional pharmacy sales will be affected.
, general manager of the health information Wu Han said that the total size of the pharmaceutical and health industry will rapidly expand in the future, but the opportunity is not alone in sharing the existing pharmaceutical companies, other non pharmaceutical industry enterprises will have to enter the field.